期刊文献+

肾小管上皮-间充质细胞转化过程中细胞迁移率的变化 被引量:2

Changes of mobility of kidney tubular epithelial cells in the course of epithelial-mesenchymal transition
原文传递
导出
摘要 目的 了解肾小管上皮-间充质细胞转化(EMT)过程中肾小管上皮细胞迁移能力的动态变化及对细胞周期的影响.方法 通过体外培养大鼠肾小管上皮细胞(NRK-52E),转化生长因子(TGF)-β1(5μg/L)诱导肾小管上皮细胞向间充质细胞转化,利用Transwell小室法以及采用流式细胞术分别观察EMT过程中细胞迁移能力的动态变化规律和细胞周期变化.结果 1.TGF-β1成功诱导EMT:TGF-β1(5μg/L)干预后,NRK-52E细胞发生形态学改变,表现为细胞排列松散,部分细胞胞体伸长,呈梭形改变;Western blot发现干预后的NRK-52E细胞上皮标志物E-cadherin表达明显下调(P<0.05),间质细胞标志物α-平滑肌肌动蛋白(α-SMA)表达增强(P<0.05),且两者均呈时间依赖性变化.2.TGF-β1体外诱导大鼠肾小管上皮细胞EMT过程中,TGF-β1干预后12 h细胞迁移能力明显增强,且随着时间的推移细胞迁移能力增强更为显著(与空白对照组比较,P<0.01).3.EMT过程中,细胞周期S期的比例随时间变化并未发生明显改变(与空白对照组比较,P>0.05).结论 TGF-β1体外诱导NRK-52E发生EMT过程中其细胞迁移能力不断增强,而细胞周期并未发生明显改变. Objective To evaluate the dynamic changes of cell mobility of renal tubular epithelial cells in the course of epithelial-mesenchymal transition(EMT) and their effect on cell cycle.Methods NRK-52E cells were cultured in vitro and treated with 5 μg/L transforming growth factor(TGF)-β1 to induce EMT.The cell mobility was assessed by using Transwell chamber assay and flow cytometry (FCW) after being treated with TGF-β1 for 4 h,8 h,12 h,24 h and 48 h.The proliferative cell cycle of NRK-52E cells were evaluated by using the FCW.Results 1.EMT was successfully induced by TGF-β1.After being treated by TGF-β1 (5 μg/L),the morphological changes of NRK-52E cells were found with loose cell arrangement and elongated fusiform change in cells body.Meanwhile,after getting treated by TGF-β1,the expressions of E-cadherin protein(epithelial marker) of NRK-52E cells were significantly decreased with time-dependent (P < 0.05),while the expressions of α-smooth musle actin (α-SMA) (mesenchymal cell marker)were significantly increased with time-dependent (P < 0.05).2.The Transwell chamber assay showed that compared with the control group,the cell mobility in the group treated with TGF-β1 was significantly enhanced from 12 h after getting treated with TGF-β1 (P < 0.01).3.The proliferative cell cycle of NRK-52E cells showed no significant difference after being treated with TGF-β1 (P > 0.05).Conclusions The migration ability of the NRK-52E cells are increased incessantly in the course of EMT,which is induced by TGF-β1 without the influence of cell proliferation in vitro.
出处 《中华实用儿科临床杂志》 CAS CSCD 北大核心 2013年第17期1302-1305,共4页 Chinese Journal of Applied Clinical Pediatrics
基金 国家自然科学基金(30871177) 上海市科委科研项目(114119a1700)
关键词 肾小管上皮-间充质细胞转化 肾间质纤维化 慢性肾脏疾病 转化生长因子-Β1 细胞周期 Epithelial-mesenchymal transition Renal tubulointerstitial fibrosis Chronic kidney disease Transforming growth factor-β1 Cell cycle
  • 相关文献

参考文献14

  • 1Franquesa M,Herrero E,Torras J. Mesenchymal stem cell therapy prevents interstitial fibrosis and tubular atrophy in a rat kidney allograft model[J].Stem Cells and Development,2012,(17):3125-3135.
  • 2Xiong M,Gong J,Liu Y. Loss of vitamin D receptor in chronic kidney disease:a potential mechanism linking inflammation to epithelial-tomesenchymal transition[J].American Journal of Physiology-Renal Physiology,2012,(07):1107-1115.
  • 3Carew RM,Wang B,Kantharidis P. The role of the EMT in renal fibrosis[J].Cell and Tissue Research,2012,(01):103-116.
  • 4Ding H,Zhou D,Hao S. Sonic hedgehog signaling mediates epithelial-mesenchymal communication and promotes renal fibrosis[J].Journal of the American Society of Nephrology,2012,(05):801-813.
  • 5Yang YL,Ju HZ,Liu SF. BMP-2 suppresses renal interstitial fibrosis by regulating epithelial-mesenchymal transition[J].Journal of Cellular Biochemistry,2011,(09):2558-2565.
  • 6韩玫瑰,孙俊娥,樊爱英,韩子明.水飞蓟素对肾小管间质纤维化大鼠转化生长因子-β_1 mRNA和金属蛋白酶组织抑制物-1 mRNA表达的影响[J].新乡医学院学报,2011,28(4):418-421. 被引量:9
  • 7Yang J,Liu Y. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis[J].American Journal of Pathology,2001,(04):1465-1475.
  • 8Huang WY,Li ZG,Rus H. RGC-32 mediates transforming growth factor-beta-induced epithelial-mesenchymal transition in human renal proximal tubular cells[J].Journal of Biological Chemistry,2009,(14):9426-9432.
  • 9Barnes JL,Glass WF 2nd. Renal interstitial fibrosis:a critical evaluation of the origin of myofibroblasts[J].Contributions to Nephrology,2011.73-93.
  • 10Grgic I,Duffield JS,Humphreys BD. The origin of interstitial myofibroblasts in chronic kidney disease[J].Pediatric Nephrology,2012,(02):183-193.

二级参考文献16

  • 1赵宗江,刘昆,张新雪,牛建昭.异病同治和同病异治理论在多器官纤维化防治中的应用[J].中医杂志,2005,46(10):727-729. 被引量:19
  • 2Tapmeier T T, Brown K L,Tang Z,et al. Reimplantation of the u- reter after unilateral ureteral obstruction provides a model that al- lows functional evaluation [ J ]. Kidney lnt, 2008,73 ( 7 ) : 885- 889.
  • 3Jeong D H, Lee G P, Jeong W I, et al. Alterations of mast cells and TGF-betal on the silymarin treatment for CCI4-induced he- patic fibrosis [ J]. World J Gastroenterol, 2005,11 ( 8 ) : 1141- 1148.
  • 4Singh R P, Deep G, Chittezhath M,et al. Effect of silibinin on the growth and progression of primary lung tumors in mice[ J]. J Natl Cancer lnst,2006,98 ( 12 ) :846-855.
  • 5Song Z,Deaciuc I,Song M,et al. Silymarin protects against acute ethanol-induced hepatotoxicity in mice[ J]. Alcohol Clin Exp Res, 2006,30( 3 ) :407-413.
  • 6Sobolova L, Skottova N, Vecera R,et al. Effect of silymarin and its polyphenolic fraction on cholesterol absorption in rats [ J ]. Phar- macol Res,2006,53 (2) :104-112.
  • 7Zeisberg M, Neilson E G. Mechanisms of tubulointerstitial fibrosis [ J]. J Am Soc Nephrol,2010,21 ( 11 ) : 1819-1834.
  • 8Crocenzi F A, Roma M G. Silymarin as a new hepatoprotective a- gent in experimental cholestasis: new possibilities for an ancient medication [ J ]. Curr Med Chem,2006,13 ( 9 ) : 1055-1074.
  • 9Chevalier R L, Forbes M S, Thomhill B A. Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy [ J ]. Kidney Int,2009,75(11 ) :1145-1152.
  • 10Mezzano S A, Droguett M A, Burgos M E, et al. Overexpression of chemokines fibrogenetie eytokines and myofibroblasts in human membranous nephropathy [ J]. K/dney lnt ,2000,57 ( 1 ) : 147-158.

共引文献8

同被引文献25

  • 1Badea TC,Niculescu FI,Soane L,et al.Molecular cloning and characterization of RGC-32,a novel gene induced by complement activation in oligodendrocytes[J].J Biol Chem,1998,273 (41):26977-26981.
  • 2Vlaicu S,Cudricl C,Ito T,et al.Role of response gene to complement 32 in diseases[J].Arch Immunol Ther Exp (Warsz),2008,56 (2):115-122.
  • 3Saigusa K,Imoto I,Tanikawa C,et al.RGC32,a novel P53-induclble gene,is located on centrosomes during mitosis and results in G2/M arrest[J].Oncogene,2007,26 (8):1110-1121.
  • 4Vlaicu SI,Tegla CA,Cudricl CD,et al.Epigenetic modifications induced by RGC-32 in colon cancer[J].Exp Mol Pathol,2010,88 (1):67-76.
  • 5Tegla CA,Cudricl CD,Azimzadeh P,et al.Dual role of Response gene to complement-32 in multiple sclerosis[J].Exp Mol Pathol,2013,94(1):17-28.
  • 6Badea T,Niculescu F,Soane L,et al.RGC-32 increasesP34CDC2 kinase activity and entry of aortic smooth musclecells into S-phase[J].J Biol Chem,2002,277(1):502-508.
  • 7Fosbrink M,Cudricl C,Tegla CA,et al.Response gene to complement 32 is required for C5b-9 induced cell cycle activation in endothelial cells[J].Exp Mol Pathol,2009,86(2):87-94.
  • 8Huang WY,Li ZG,Rus H,et al.Response gene to complement 32 mediates transforming growth factor β-induced epithelial-mesenchymal transition in human renal proximal tubular cells[J].J Biol Chem,2009,284 (14):9426-9432.
  • 9Fosbrink M,Cudricl C,Niculescu F,et al.Overexpression of RGC-32 in colon cancer and other tumors[J].Exp Mol Pathol,2005,78 (2):116-122.
  • 10Li F,Luo Z,Huang WY,et al.Respose gene to complement 32,a novel regulator for transforming growth factor-beta-induced smooth muscle differentiation of neural crest cells[J].J Biol Chem,2007,282(14):10133-10137.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部